Overall, the present study not only enriched the pathogenic variant spectrum of BRCA1/2 but also suggested that a high-risk Chinese population of breast cancer might benefit from genetic screening using these recurrent loci. The gene discussed is BRCA1; the disease is breast carcinoma.